Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001787306-25-000106
Filing Date
2025-07-14
Accepted
2025-07-14 16:02:23
Documents
3
Period of Report
2025-07-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1752523337.html 4  
1 FORM 4 wk-form4_1752523337.xml 4 13435
2 EX-24.1 burnettpowerofattorney20.htm EX-24.1 4323
3 burnettpowerofattorney20001.jpg GRAPHIC 255975
  Complete submission text file 0001787306-25-000106.txt   372036
Mailing Address C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380
Business Address
Burnett Patrick (Reporting) CIK: 0001741987 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39186 | Film No.: 251121756

Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Issuer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)